This company does not have a meaningful dividend profile under this framework.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (0) × 0.40 + Growth (0) × 0.35 + Income (0) × 0.25 = 0
Dividend Safety
Earnings Payout
Not reported
FCF Payout
0.0%
FCF Coverage
–
Dividend Growth
Per Share (TTM)
€0.00
Growth Streak
–
CAGR
–
Dividend history
| Fiscal year | Per share | Change |
|---|---|---|
| 2022 | €0.15 |
All 1 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.
Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.
Does NanoRepro (NN6.XETR) pay a dividend?
Frequently asked
Does NanoRepro (NN6.XETR) pay a dividend?+
No. NanoRepro (NN6.XETR) does not currently pay a dividend. The last payment in our data was in 2022, and nothing has been paid since.
How does NanoRepro return cash to shareholders?+
Through share buybacks rather than dividends. Over the last twelve months NanoRepro reduced its share count at a rate equivalent to a 1.0% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.
Could NanoRepro afford to pay a dividend?+
On the numbers, yes. NanoRepro generated €9 million of free cash flow, which is about €0.75 per share. If it paid out half of that, the dividend would be roughly €0.37 per share, a yield of about 23.8% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with NanoRepro.
Peers
Diagnostics & Research · Pick stocks to compare with NN6.XETR
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NN6.XETR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.